Antiangiogenic VEGF isoform in inflammatory myopathies

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Volpi, Nila ^a   Pecorelli, Alessandra ^b,c   Lorenzoni, Paola ^a   Di Lazzaro, Francesco ^a   Belmonte, Giuseppe ^a   Aglianò, Margherita ^a   Cantarini, Luca ^a   Giannini, Fabio ^a   Grasso, Giovanni ^a   Valacchi, Giuseppe ^d,e  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN 165; VASCULOTROPIN A; ISOPROTEIN;

ADULT; AGED; ARTICLE; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; MUSCLE REGENERATION; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TISSUE DISTRIBUTION; UPREGULATION; VASCULARIZATION; WESTERN BLOTTING; INCLUSION BODY MYOSITIS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BLOTTING, WESTERN; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS; PROTEIN ISOFORMS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880176526     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/219313     Document Type: Article

References (29)

1. Dalakas M. C., Review: an update on inflammatory and autoimmune myopathies. Neuropathology and Applied Neurobiology 2011 37 3 226 242 2-s2.0-79951801084 10.1111/j.1365-2990.2010.01153.x
2. Raju R., Dalakas M. C., Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 2005 128 8 1887 1896 2-s2.0-23444456921 10.1093/brain/awh518 (Pubitemid 41373661)
3. Grundtman C., Lundberg I. E., Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies. Autoimmunity 2009 42 7 615 626 2-s2.0-71049133435 10.1080/08916930903002511
4. Dalakas M. C., Immunotherapy of inflammatory myopathies: practical approach and future prospects. Current Treatment Options in Neurology 2011 13 3 311 323 2-s2.0-79955875727 10.1007/s11940-011-0119-8
5. Nowak D. G., Woolard J., Amin E. M., Konopatskaya O., Saleem M. A., Churchill A. J., Ladomery M. R., Harper S. J., Bates D. O., Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. Journal of Cell Science 2008 121 20 3487 3495 2-s2.0-56349136033 10.1242/jcs.016410
6. Bates D. O., Cui T.-G., Doughty J. M., Winkler M., Sugiono M., Shields J. D., Peat D., Gillatt D., Harper S. J., VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Research 2002 62 14 4123 4131 2-s2.0-0037098860 (Pubitemid 34791084)
7. Woolard J., Wang W.-Y., Bevan H. S., Qiu Y., Morbidelli L., Pritchard-Jones R. O., Cui T.-G., Sugiono M., Waine E., Perrin R., Foster R., Digby-Bell J., Shields J. D., Whittles C. E., Mushens R. E., Gillatt D. A., Ziche M., Harper S. J., Bates D. O., VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Research 2004 64 21 7822 7835 2-s2.0-7444240909 10.1158/0008-5472.CAN-04-0934 (Pubitemid 39446915)
8. Olfert M. I., Howlett R. A., Tang K., Dalton N. D., Gu Y., Peterson K. L., Wagner P. D., Breen E. C., Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. Journal of Physiology 2009 587 8 1755 1767 2-s2.0-65249181467 10.1113/jphysiol.2008.164384
9. Ryan N. A., Zwetsloot K. A., Westerkamp L. M., Hickner R. C., Pofahl W. E., Gavin T. P., Lower skeletal muscle capillarization and VEGF expression in aged vs. young men. Journal of Applied Physiology 2006 100 1 178 185 2-s2.0-33644828312 10.1152/japplphysiol.00827.2005 (Pubitemid 43671106)
10. Wagatsuma A., Endogenous expression of angiogenesis-related factors in response to muscle injury. Molecular and Cellular Biochemistry 2007 298 1-2 151 159 2-s2.0-34247211731 10.1007/s11010-006-9361-x (Pubitemid 46605292)
11. Grundtman C., Tham E., Ulfgren A.-K., Lundberg I. E., Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis & Rheumatism 2008 58 10 3224 3238 2-s2.0-54149119474 10.1002/art.23884
12. Qiu Y., Hoareau-Aveilla C., Oltean S., Harper S. J., Bates D. O., The anti-angiogenic isoforms of VEGF in health and disease. Biochemical Society Transactions 2009 37 6 1207 1213 2-s2.0-70450203391 10.1042/BST0371207
13. Bates D. O., MacMillan P. P., Manjaly J. G., Qiu Y., Hudson S. J., Bevan H. S., Hunter A. J., Soothill P. W., Read M., Donaldson L. F., Harper S. J., The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clinical Science 2006 110 5 575 585 2-s2.0-33646711885 10.1042/CS20050292 (Pubitemid 43736120)
14. Varey A. H. R., Rennel E. S., Qiu Y., Bevan H. S., Perrin R. M., Raffy S., Dixon A. R., Paraskeva C., Zaccheo O., Hassan A. B., Harper S. J., Bates D. O., VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. British Journal of Cancer 2008 98 8 1366 1379 2-s2.0-42149152015 10.1038/sj.bjc.6604308 (Pubitemid 351543576)
15. Gustafsson T., Ameln H., Fischer H., Sundberg C. J., Timmons J. A., Jansson E., VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. Journal of Applied Physiology 2005 98 6 2137 2146 2-s2.0-19444386664 10.1152/japplphysiol.01402.2004 (Pubitemid 40726908)
16. Jones W. S., Duscha B. D., Robbins J. L., Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training. Vascular Medicine 2012 17 2 94 100
17. Nowak D. G., Amin E. M., Rennel E. S., Hoareau-Aveilla C., Gammons M., Damodoran G., Hagiwara M., Harper S. J., Woolard J., Ladomery M. R., Bates D. O., Regulation of Vascular Endothelial Growth Factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. The Journal of Biological Chemistry 2010 285 8 5532 5540 2-s2.0-77949318969 10.1074/jbc.M109.074930
18. Perrin R. M., Konopatskaya O., Qiu Y., Harper S., Bates D. O., Churchill A. J., Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 2005 48 11 2422 2427 2-s2.0-27744489034 10.1007/s00125-005-1951-8 (Pubitemid 41618935)
19. Ergorul C., Ray A., Huang W., Darland D., Luo Z. K., Grosskreutz C. L., Levels of vascular endothelial growth factor-A165b (VEGF-A165b) are elevated in experimental glaucoma. Molecular Vision 2008 14 1517 1524 2-s2.0-50549086120
20. Manetti M., Guiducci S., Romano E., Ceccarelli C., Bellando-Randone S., Conforti M. L., Ibba-Manneschi L., Matucci-Cerinic M., Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Circulation Research 2011 109 3 e14 e26 2-s2.0-79961031252 10.1161/CIRCRESAHA. 111.242057
21. Manetti M., Guiducci S., Ibba-Manneschi L., Matucci-Cerinic M., Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant. Trends in Cardiovascular Medicine 2011 21 7 204 210
22. Confalonieri P., Bernasconi P., Cornelio F., Mantegazza R., Transforming growth factor- β 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. Journal of Neuropathology & Experimental Neurology 1997 56 5 479 484 2-s2.0-0030781193 (Pubitemid 27463089)
23. Marotta M., Sarria Y., Ruiz-Roig C., Munell F., Roig-Quilis M., Laser microdissection-based expression analysis of key genes involved in muscle regeneration in mdx mice. Neuromuscular Disorders 2007 17 9-10 707 718 2-s2.0-34548389286 10.1016/j.nmd.2007.05.007 (Pubitemid 47362678)
24. Englund P., Lindroos E., Nennesmo I., Klareskog L., Lundberg I. E., Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. American Journal of Pathology 2001 159 4 1263 1273 2-s2.0-0034790176 (Pubitemid 32947956)
25. Cui T.-G., Foster R. R., Saleem M., Mathieson P. W., Gillatt D. A., Bates D. O., Harper S. J., Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein. American Journal of Physiology 2004 286 4 F767 F773 2-s2.0-1642280409 (Pubitemid 38365096)
26. Esposito F., Mathieu-Costello O., Entin P. L., Wagner P. D., Richardson R. S., The skeletal muscle VEGF mRNA response to acute exercise in patients with chronic heart failure. Growth Factors 2010 28 2 139 147 2-s2.0-77949432925 10.3109/08977190903512602
27. Gustafsson T., Puntschart A., Kaijser L., Jansson E., Sundberg C. J., Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. American Journal of Physiology 1999 276 2 H679 H685 2-s2.0-0033030182 (Pubitemid 29100638)
28. Falanga V., Qian S. W., Danielpour D., Katz M. H., Roberts A. B., Sporn M. B., Hypoxia upregulates the synthesis of TGF- β 1 by human dermal fibroblasts. Journal of Investigative Dermatology 1991 97 4 634 637 2-s2.0-0025943515
29. Magnussen A. L., Rennel E. S., Hua J., Bevan H. S., Long N. B., Lehrling C., Gammons M., Floege J., Harper S. J., Agostini H. T., Bates D. O., Churchill A. J., VEGF-A165B is cytoprotective and antiangiogenic in the retina. Investigative Ophthalmology and Visual Science 2010 51 8 4273 4281 2-s2.0-77955866848 10.1167/iovs.09-4296